Ernesto Millan
Neurology with Special Qualifications in Child Neurology · Tampa, FLNPI 1083735856
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 676 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Tris Pharma Inc at 29.4% of the total.
Across 676 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$3K
- UCB, Inc.$1K
- Corium, LLC$1K
- Jazz Pharmaceuticals Inc.$831
- Supernus Pharmaceuticals, Inc.$733
- Neurelis, Inc.$490
- plus $4K from 23 others
What the payments were for
- Food & beverage$11,440100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 268 | $3,366 |
| UCB, Inc. | 78 | $1,405 |
| Corium, LLC | 79 | $1,090 |
| Jazz Pharmaceuticals Inc. | 30 | $831 |
| Supernus Pharmaceuticals, Inc. | 64 | $733 |
| Neurelis, Inc. | 22 | $490 |
| SK Life Science, Inc. | 4 | $485 |
| Ironshore Pharmaceuticals Inc. | 27 | $484 |
| Eisai Inc. | 14 | $364 |
| Aquestive Therapeutics, Inc. | 15 | $362 |
| Noven Therapeutics, LLC | 11 | $227 |
| Neos Therapeutics, LP | 12 | $192 |
| Mallinckrodt Enterprises LLC | 3 | $166 |
| Sumitomo Pharma America, Inc. | 9 | $153 |
| Sunovion Pharmaceuticals Inc. | 2 | $148 |
| Acadia Pharmaceuticals Inc | 2 | $146 |
| Neuropace, Inc. | 1 | $129 |
| Greenwich Biosciences, Inc. | 4 | $115 |
| Livanova USA, Inc. | 3 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $87 |
| Collegium Pharmaceutical, Inc. | 5 | $81 |
| Catalyst Pharmaceuticals, Inc. | 4 | $67 |
| Immedica Pharma US, Inc. | 3 | $49 |
| Zogenix Inc. | 2 | $48 |
| Adlon Therapeutics L.p. | 2 | $37 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Cranial Technologies, Inc | 2 | $34 |
| Otter Pharmaceuticals, LLC | 1 | $16 |
| Aprecia Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XCOPRI$360
- Epidiolex$134
- RNS Neurostimulator Kit$129
- Fycompa$125
- Jornay PM 20mg capsules (Bottle of 100)$125
- QELBREE$125
- ACTHAR$125
- Cenobamate$125
- SYMPAZAN$124
- APTIOM$123
- DAYBUE$123
- Briviact$117
- VALTOCO$114
- Azstarys$114
How this compares
$11,447 in reported general payments places this provider in the 70th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Tampa
- Jose FerreiraTampa$88K
- Eric VernierTampa$33K
- Anne CsereTampa$29K
- Sergio JacintoTampa$21K
- Jose ForadadaTampa$13K
- Sagarika NalluTampa$7K
- Paul WinnerWest Palm Beach$624K
- Omer Abdul HamidOrlando$283K
- Natalie GillsonFort Myers$250K
- Trevor ResnickMiami$230K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.